Literature DB >> 12150613

Quality of life after parotid and temporal bone surgery for cancer.

Henry C K Kwok1, Randall P Morton, John M Chaplin, Nicholas P McIvor, Hamish A Sillars.   

Abstract

OBJECTIVES: The purposes of this study were to examine the quality of life (QL) of patients who received treatment for cancer of the parotid or temporal region, and to identify factors contributing to it. The relationships between clinician-based measures of treatment outcome and the patient-based counterparts were also evaluated.
METHODS: A retrospective, cross-sectional study was conducted on 23 patients who had received either a temporal bone resection or a combination of parotidectomy and radiotherapy. The QL survey involved both global QL and measures of the appearance, communication, hearing, physical, psychological, and social domains. Patients were assessed clinically for their performance status, facial nerve function, disfigurement, and hearing and the results were compared with patient-rated QL. Correlation between the QL variables and global QL was identified using Spearman correlation tests.
RESULTS: Ongoing physical symptoms, communication difficulties, and social disturbances were associated with poorer global QL (P <.05). No correlation was detected between global QL and objective disfigurement, facial function, and measures of hearing loss. With the exception of hearing testing, clinical assessments generally did not correlate well with patient ratings.
CONCLUSION: QL measures provide insight into patients' perceptions of the treatment outcome but do not necessarily correlate with the clinicians' views. The use of a global QL measure overcomes the difficulty of extrapolating the impact of symptom scores or observational measures on patients' overall quality of survival.

Entities:  

Mesh:

Year:  2002        PMID: 12150613     DOI: 10.1097/00005537-200205000-00010

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Outcomes of temporal bone resection for locally advanced parotid cancer.

Authors:  Saral Mehra; Luc G Morris; Jatin Shah; Mark Bilsky; Samuel Selesnick; Dennis H Kraus
Journal:  Skull Base       Date:  2011-11

2.  Quality of life following endonasal skull base surgery.

Authors:  Harshita Pant; Amol M Bhatki; Carl H Snyderman; Allan D Vescan; Ricardo L Carrau; Paul Gardner; Daniel Prevedello; Amin B Kassam
Journal:  Skull Base       Date:  2010-01

3.  Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia.

Authors:  Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

4.  Health-related quality of life in patients with major salivary gland carcinoma.

Authors:  Christoph Becker; Jens Pfeiffer; Kitty Lange; Kilian Konrad Kenjiro Dahlem
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-24       Impact factor: 2.503

5.  Invasion Patterns of External Auditory Canal Squamous Cell Carcinoma: A Histopathology Study.

Authors:  Omer J Ungar; Felipe Santos; Joseph B Nadol; Gilad Horowitz; Dan M Fliss; William C Faquin; Ophir Handzel
Journal:  Laryngoscope       Date:  2020-04-20       Impact factor: 3.325

6.  Determinants for further wishes for cosmetic and reconstructive interventions in 1652 patients with surgical treated carcinomas of the oral cavity.

Authors:  Henrik Holtmann; Simon Spalthoff; Nils-Claudius Gellrich; Jörg Handschel; Julian Lommen; Norbert R Kübler; Gertrud Krüskemper; Majeed Rana; Karoline Sander
Journal:  Maxillofac Plast Reconstr Surg       Date:  2017-09-05

7.  Clinical experience of 23 cases of adenoid cystic carcinoma of the external auditory canal.

Authors:  Xiaojun Jiang; Lifeng Jia; Xueyuan Zhang; Cheng Zhong; Feng Tang; Xiaoling Chen; Wei Yuan
Journal:  Oncol Lett       Date:  2020-08-21       Impact factor: 2.967

Review 8.  The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure.

Authors:  J Hendry; A Chin; I R C Swan; M A Akeroyd; G G Browning
Journal:  Clin Otolaryngol       Date:  2016-02-07       Impact factor: 2.597

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.